RKIP overexpression in breast and prostate cancer cell lines was shown to inhibit cellular Src (c-Src) autophosphorylation and activation, as well as interleukin 6 (IL-6)-, janus kinase 1/2 (JAK1/2)-, and activated Raf-mediated STAT3 tyrosine and serine phosphorylation, needed for STAT3 activation. Here, IL6 is linked to prostate cancer.